Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Spinoff company formed to produce hormone supplement that reduces lung damage, but researchers still need to convince federal ...

A new study distinguishes between two distinct phases of Alzheimer's disease: an early, 'stealth' one without symptoms, and a ...

A group of major research organizations published cutting edge research that uses computer modeling to make a first of it's ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

While lecanemab is approved for use in USA, Japan, China, South Korea and Israel, the European Medicines Agency (EMA) refused ...

POTOMAC, MD / ACCESSWIRE / October 17, 2024 / IGC Pharma, Inc (NYSE American:IGC) ("IGC" or the "Company"), today announced enrollment of patients at the Baycrest Academy for Research and Education in ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

"The results fundamentally alter scientists' understanding of how Alzheimer's harms the brain," researchers say.

Recent research is looking at the way in which cardiovascular issue may play into the development of dementia, with one study ...

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar ...

By obtaining high-resolution images of Alzheimer’s disease-affected brain cells as the condition progresses, researchers have identified the specific neurons that are damaged. The information the ...